EP1146904A4 - Verwendung von hydroxyharnstoff und einem hemmstoff der reversen transkriptase zur induktion einer autovakzination durch autologes hiv - Google Patents
Verwendung von hydroxyharnstoff und einem hemmstoff der reversen transkriptase zur induktion einer autovakzination durch autologes hivInfo
- Publication number
- EP1146904A4 EP1146904A4 EP00905949A EP00905949A EP1146904A4 EP 1146904 A4 EP1146904 A4 EP 1146904A4 EP 00905949 A EP00905949 A EP 00905949A EP 00905949 A EP00905949 A EP 00905949A EP 1146904 A4 EP1146904 A4 EP 1146904A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- autovaccination
- hydroxyurea
- induce
- reverse transcriptase
- transcriptase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24375399A | 1999-02-03 | 1999-02-03 | |
US243753 | 1999-02-03 | ||
US09/493,769 US20030095988A1 (en) | 2000-01-28 | 2000-01-28 | Method of inducing autovaccination against HIV infection using structured treatment interruptions |
US493769 | 2000-01-28 | ||
PCT/US2000/002754 WO2000045844A1 (en) | 1999-02-03 | 2000-02-02 | Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1146904A1 EP1146904A1 (de) | 2001-10-24 |
EP1146904A4 true EP1146904A4 (de) | 2004-09-15 |
Family
ID=26936052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00905949A Withdrawn EP1146904A4 (de) | 1999-02-03 | 2000-02-02 | Verwendung von hydroxyharnstoff und einem hemmstoff der reversen transkriptase zur induktion einer autovakzination durch autologes hiv |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1146904A4 (de) |
AU (1) | AU2753700A (de) |
WO (1) | WO2000045844A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030095988A1 (en) * | 2000-01-28 | 2003-05-22 | Julianna Lisziewicz | Method of inducing autovaccination against HIV infection using structured treatment interruptions |
FR2821556B1 (fr) * | 2001-03-02 | 2003-04-25 | Aventis Pasteur | Utilisation de lipopeptides pour l'immunotherapie des sujets vih+ |
CA2435568A1 (en) * | 2001-01-26 | 2002-08-01 | The Immune Response Corporation | Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994027590A1 (en) * | 1993-05-21 | 1994-12-08 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
WO1996022777A1 (en) * | 1995-01-25 | 1996-08-01 | Compagnie De Developpement Aguettant | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
US5521161A (en) * | 1993-12-20 | 1996-05-28 | Compagnie De Developpment Aguettant S.A. | Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
US6114312A (en) * | 1997-03-07 | 2000-09-05 | Research Institute For Genetic And Human Therapy (R.I.G.H.T.) | Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor |
-
2000
- 2000-02-02 EP EP00905949A patent/EP1146904A4/de not_active Withdrawn
- 2000-02-02 AU AU27537/00A patent/AU2753700A/en not_active Abandoned
- 2000-02-02 WO PCT/US2000/002754 patent/WO2000045844A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994027590A1 (en) * | 1993-05-21 | 1994-12-08 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
WO1996022777A1 (en) * | 1995-01-25 | 1996-08-01 | Compagnie De Developpement Aguettant | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread |
Non-Patent Citations (1)
Title |
---|
See also references of WO0045844A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1146904A1 (de) | 2001-10-24 |
AU2753700A (en) | 2000-08-25 |
WO2000045844A1 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG80631A1 (en) | Inhibitors of hiv reverse transcriptase | |
AU6202900A (en) | Restoration of a computer to a previous state | |
SK5342002A3 (en) | Tricyclic compounds useful as HIV reverse transcriptase inhibitors | |
HK1080852A1 (en) | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors | |
IL150756A0 (en) | Novel use of hiv proteins | |
AU1046895A (en) | New quinazolines as inhibitors of hiv reverse transcriptase | |
NO953308D0 (no) | Inhibitorer av HIV revers transkriptase | |
IL155371A0 (en) | Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents | |
ID28436A (id) | Alat pemakai untuk tampon | |
AU2001247434A1 (en) | Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof | |
EP1146904A4 (de) | Verwendung von hydroxyharnstoff und einem hemmstoff der reversen transkriptase zur induktion einer autovakzination durch autologes hiv | |
PL340239A1 (en) | Corrosion inhibitor to be added to a gas treatment colution | |
AU2001270193A1 (en) | Pharmaceutical composition containing psyllium fiber and a lipase inhibitor | |
HUT71401A (en) | New quinazolines as inhibitors of hiv reverse transcriptase | |
HK1053334A1 (zh) | 植物組學:涉及草藥組合物的基於基因組的方法 | |
EP1572291A4 (de) | Verwendung von zytokin, das il-18bp binden und die wirkung eines zweiten zytokins hemmen kann | |
NO20030248D0 (no) | Tricykliske pyridonforbindelser anvendelige som HIV revers- transkriptase-inhibitorer | |
ID24940A (id) | Pemakaian ketolida-ketolida untuk pencegahan komplikasi trombotik arteri mengenai aterosklerosis | |
AU2002218610A1 (en) | Improvements in or relating to a tampon | |
AU2003277268A8 (en) | Therapeutic aptamers having binding specificity to gp41 of hiv | |
AU2119695A (en) | Synergistic inhibition of hiv-1 infection using a nucleoside reverse transcriptase inhibitor and anti-hiv-1 antibodies | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
CA101611S (en) | Paper napkin | |
AU2002237251A1 (en) | A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv | |
GB0009619D0 (en) | Materials and methods relating to increasing retroviral titre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010809 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010809;LT PAYMENT 20010809;LV PAYMENT 20010809;MK PAYMENT 20010809;RO PAYMENT 20010809;SI PAYMENT 20010809 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040729 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040901 |